MODIFICATION
B -- Bioequivalence Studies of Generic Antiepileptic Drugs - Bioequivalence Studies - RFI
- Notice Date
- 3/19/2012
- Notice Type
- Modification/Amendment
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- RFI-1099605
- Archive Date
- 4/17/2012
- Point of Contact
- Christopher E. Cunningham, Phone: 301-827-7185, Doreen Williams,
- E-Mail Address
-
christopher.cunningham@fda.hhs.gov, doreen.williams@fda.hhs.gov
(christopher.cunningham@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- RFI - BE Studies This amendment addresses the page length of responses.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/RFI-1099605/listing.html)
- Record
- SN02700124-W 20120321/120319235457-b01ef49bcc4b17c2f811eae91565d50e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |